Citation: | MINYu, YUANDe-pei, HUYu-ping, ZENGChu-hua, HANLong, TANDeng, WANShi-wei, MINWen. Effect of Erzhi Wan on Bone Metabolism in Rats with Ovariectomized Osteoporosis[J]. Journal of Nanjing University of traditional Chinese Medicine, 2020, 36(2): 215-220. |
[1] |
中国骨质疏松症流行病学调查及“健康骨骼”专项行动结果发布[J].中华骨质疏松和骨矿盐疾病杂志,2019,12(4):317-318.
|
[2] |
葛运华,吴伟.糖尿病患者骨代谢的变化及运动对其影响的研究进展[J].中国骨质疏松杂志,2016,22(11):1491-1495.
|
[3] |
苏华,黎涛,廖碧芝.脂代谢与骨代谢信号通路及与骨代谢相关疾病的关系研究进展[J].中国医药科学,2019,9(17):63-65.
|
[4] |
郭耀,霍建忠,吴斗,等.chemerin信号通路在骨质疏松症中的作用[J].中国骨质疏松杂志,2018,24(12):1671-1675.
|
[5] |
王裕祥.血清Chemerin水平与骨质疏松症患者骨密度的相关性研究[J].中国骨质疏松杂志,2019,25(8):1129-1133.
|
[6] |
王浩,程玲,朱旭华,等.自拟“二至更年汤”治疗肝肾阴虚型围绝经期综合征临床研究[J].天津中医药,2018,35(3):170-174.
|
[7] |
冀志芹,崔骞.二仙汤二至丸合方治疗围绝经期综合征369例疗效观察[J].中医临床研究,2017,9(34):108-109.
|
[8] |
梁文娜,李西海,胡柳,等.二至丸抑制绝经后骨质疏松大鼠骨代谢紊乱的作用机制研究[J].中医正骨,2017,29(11):1-7.
|
[9] |
薛继强,王琦,谢根东,等.从肾阳虚论治骨质疏松症浅析[J].陕西中医,2008(7):936.
|
[10] |
胡科.二至丸对骨质疏松性股骨颈骨折术后愈合及髋关节功能的影响[J].现代中西医结合杂志,2017,26(4):384-386.
|
[11] |
梁文娜,李西海,胡柳,等.二至丸抑制绝经后骨质疏松大鼠骨代谢紊乱的作用机制研究[J].中医正骨,2017,29(11):1-7.
|
[12] |
ELENA C, CLAUDIA D, GIOIA MM, et al. RNA isolation from alveolar bone and gene expression analysis of RANK,RANKL and OPG:A new tool to monitor bone remodeling and healing in different bone substitutes used for prosthetic rehabilitation[J].Arch Oral Biol,2017,80(1):56-61.
|
[13] |
LALEH P, FARZAM SH, RAFIGHE G, et al. The impact of forced swimming on expression of RANKL and OPG in a type 2 diabetes mellitus rat model[J].Arch Int Physiol,2019, 125(3):195-200.
|
[14] |
WANG CM, TSAI SC, LIN JC, et al. Association of genetic variants of RANK, RANKL and OPG with ankylosing spondylitis clinical features in taiwanese[J]. Med Inflam,2019,2019(5):1-14.
|
[15] |
廖秀风,陈叶.基于MicroRNA介导Wnt/β-catenin通路防治绝经后骨质疏松的中西医研究进展[J].现代中西医结合杂志,2019,28(29):3298-3303.
|
[16] |
MAUPIN KA, DROSCHA CJ, WILLIAMS BO. A comprehensive overview of skeletal phenotypes associated with alterations in Wnt/β-catenin signaling in humans and mice[J].Bone Res,2013,1(1):27-71.
|
[17] |
韩龙,万仕炜,王睿,等.脂肪因子与绝经后骨质疏松症关系研究进展[J].生命的化学,2018,38(4):524-528.
|
[18] |
HE J, LI JC, XIE H, et al. Serum chemerin levels in relation to osteoporosis and bone mineral density: A case-control study[J].Dis Mark,2015,2015: 1-6.
|
[19] |
陈曾,徐展望,向亮,等.脂肪因子chemerin与骨质疏松症的关系展望[J].中国骨质疏松杂志,2015,21(2):231-234.
|
[20] |
MURUGANANDAN S, DRANSE HJ, ROURKE JL, et al. Chemerin neutralization blocks hematopoietic stem cell osteoclastogenesis[J].Stem Cells,2013,31(10):2172-2182.
|
[21] |
MURUGANANDAN S, GOVINDARAJAN R, MCMULLEN NM, et al. Chemokine-like receptor 1 is a novel Wnt target gene that regulates mesenchymal stem cell differentiation[J].Stem Cells,2017,35(3): 711-724.
|
[22] |
陈巨鹏,黄桂成,李伟东,等.补肾活血健骨方含药血清对人成骨细胞增殖、分化及矿化功能的影响[J].南京中医药大学学报,2016,32(6):561-565.
|